AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference

HAYWARD, Calif., Sept. 6, 2022 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (“AcelRx”), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that Chief…